FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies Par FDA – Press releases
FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering Par FDA – Press releases
FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests Par FDA – Press releases
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People Par FDA – Press releases
